Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Hair-related body dysmorphic disorder is common in hair loss patients and needs early recognition for proper treatment.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

The lowest effective dose of Botox for detrusor sphincter dyssynergia is between 75-100 units.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

Betacellulin helps blood vessel growth in wounds but delays hair growth.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Dengue fever can cause hair loss that may lead to serious psychological issues like Body Dysmorphic Disorder in young women.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Cognitive-behavioral therapy with habit reversal training is the most effective treatment for trichotillomania.

Hair transplant improved self-perception in hair loss patients, but some still remained overly focused on their hair appearance.

Habit reversal training effectively treats hair-pulling disorder in both adults and children.

Direct-to-consumer telemedicine in Australia needs formal evaluation for safety and quality.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Direct-to-consumer teledermatology effectively treats male hair loss but may increase drug costs and requires monitoring for side effects.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

The HDDPiW-jSB solution may prevent hair loss caused by docetaxel in rats when applied regularly.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.